Immune Design Corp. Deferred Tax Assets, in Process Research and Development

Immune Design Corp. Deferred Tax Assets, in Process Research and Development

Immune Design Corp. had Deferred Tax Assets, in Process Research and Development of $2.66 million as of 2014-12-31, per its 10-K filed 2015-03-31.

Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross

us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment · last filed 2015-03-31

• 2014-12-31: Deferred Tax Assets, in Process Research and Development $2.66M.
• 2013-12-31: Deferred Tax Assets, in Process Research and Development $1.97M.